AbbVie, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical Research and Development
Lobbying Interests:
Issues related to patient healthcare and pharmaceutical sales, research and development.
CEO Name:
Richard Gonzalez
Pharmaceutical Research and Development
Lobbying Interests:
Issues related to patient healthcare and pharmaceutical sales, research and development.
CEO Name:
Richard Gonzalez
Contact
EG
Emily Gibellina
1 NORTH WAUKEGAN ROAD, DEPT. V38L, BLDG. ABV-1
NORTH CHICAGO, IL 60064
847.935.8124
Emily.Gibellina@abbvie.com
1 NORTH WAUKEGAN ROAD, DEPT. V38L, BLDG. ABV-1
NORTH CHICAGO, IL 60064
847.935.8124
Emily.Gibellina@abbvie.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 103
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/22/2023
First Communication Date
3/15/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/22/2023
First Communication Date
3/15/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Assembly Bill 773
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
2/6/2024
First Communication Date
2/2/2024
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date2/6/2024
First Communication Date
2/2/2024
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Senate Bill 100
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
3/22/2023
First Communication Date
3/12/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
Bill Text and History
For
Notification Date3/22/2023
First Communication Date
3/12/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Senate Bill 737
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
12/5/2023
First Communication Date
12/4/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
Bill Text and History
For
Notification Date12/5/2023
First Communication Date
12/4/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to the application of prescription drug payments for health coverage.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to the application of prescription drug payments for health coverage.
Development, drafting or introduction of a proposal relating to the application of prescription drug payments for health coverage.
Action Intended To Affect
Legislative matter
Notification Date
1/26/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative matter
Notification Date
1/26/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.
Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.
Action Intended To Affect
Legislative matter
Notification Date
1/26/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative matter
Notification Date
1/26/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal related to rare diseases.
Development, drafting or introduction of a proposal related to rare diseases.
Action Intended To Affect
Legislative matter
Notification Date
1/26/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative matter
Notification Date
1/26/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal Medicaid drug coverage process and procedure.
Development, drafting or introduction of a proposal Medicaid drug coverage process and procedure.
Action Intended To Affect
Legislative matter
Notification Date
1/24/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative matter
Notification Date
1/24/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2023 January - June |
2023 July - December |
2024 January - June |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2023 January - June $16,320.30 |
2023 July - December $28,458.00 |
2024 January - June $29,000.00 |
Total $73,778.30 |
| Total Hours Communicating | 2023 January - June 57.00 |
2023 July - December 22.00 |
2024 January - June 16.50 |
Total 95.50 |
| Total Hours Other | 2023 January - June 157.50 |
2023 July - December 123.00 |
2024 January - June 74.50 |
Total 355.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 34% |
2023 July - December 37% |
2024 January - June |
2024 July - December |
Total 28% |
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 34% |
2023 July - December 37% |
2024 January - June |
2024 July - December |
Total 28% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December 26% |
2024 January - June 33% |
2024 July - December |
Total 15% |
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June |
2023 July - December |
2024 January - June 67% |
2024 July - December |
Total 14% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 7% |
2023 July - December |
2024 January - June |
2024 July - December |
Total 3% |
Development, drafting or introduction of a proposal relating to the application of prescription drug payments for health coverage.
| 2023 January - June |
2023 July - December |
2024 January - June |
2024 July - December |
Total |
|---|---|---|---|---|
| 2023 January - June 25% |
2023 July - December |
2024 January - June |
2024 July - December |
Total 12% |
Minor Efforts
No minor efforts found.
Other Matters
No other matters found.